Industry News 20 Oct 2026

S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility

Source: Medical News •By cell therapies pty ltd reviewed •1 min read

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer will enable GMP manufacture of clinical trial material for S2N’s first-in-human study in Australia.

This is a short summary. The full story is published by Medical News.

Read full story at Medical News
#cell#clinical trial#gmp#hair#manufacturing#neurons#research#science and innovations#syndrome#therapy#translation#veterinary

Related news

Industry News
Zydus Lifesciences Partners Prolific Machines for Biologics Manufacturing

Zylidac Bio, a CDMO within the Zydus Lifesciences group, has partnered with Prolific Machines to scale Prolific's next-generation biologics…

Stockwatch• 21 Oct 2026 •1 min read
#gmp#good manufacturing practice#partnership
Read story
Industry News
Amgen (AMGN): The Biotech Pioneer Preparing for Its Next Growth Wave

Initially, the pharmaceutical industry was built on the ability to identify, isolate, and purify chemical compounds with medicinal virtues, for…

Securities Io• 19 Oct 2026 •1 min read
#antibiotic#pharmaceutical#research
Read story
Industry News
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
Newsbreak• 17 Oct 2026
#breaking news#fda approval#Local News
Read story
Regulatory
AMA and EMA issue joint guidance on Ebola vaccine development

EMA’s Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely start of…

EMA• 23 Oct 2026 •1 min read
#clinical trial#vaccine
Read story
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Trending tags
#pharma #pharmaceutical #fda approval #diseases #pharmaceuticals #clinical trial #fda approves #pharma and healthcare #biosimilar #phase iii #science and innovations #research #vaccine #drug #world news
Browse by category
Industry News 89 Regulatory 5
Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit